UGT1A1 and breast disorder: This increase in UGT1A1 mRNA levels in more aggressive stage of breast disease could be attributed to epigenetic regulation of UGT1A1 resulting in variations in response to chemotherapy used for the treatment of more aggressive cancers [24].